Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy.
Phase of Trial: Phase IV
Latest Information Update: 13 Nov 2013
At a glance
- Drugs Pertuzumab (Primary) ; Antineoplastics
- Indications Advanced breast cancer
- Focus Adverse reactions
- 13 Nov 2013 New trial record